aMoon — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Adicet Bioadicetbio.comNASDAQ: ACETJul 2019SEC filingmedium confidence
Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer.
BiotechHealthtechMenlo Park, US
Aya Jakobovits(Executive Officer, Director)Nathan Hubbard(Executive Officer)
BoardJonathan Silverstein(Director)inCarl Gordon(Director)inFlorent Gros(Director)Erez Chimovits(Director)in
Board seatYair Schindel· per SEC Form D · $80M raise · filed Oct 2019
Co-investorsForesite CapitalOrbiMedPontifax Venture CapitalQuan CapitalNovartis Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.